CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 ORIC Pharmaceuticals, Inc. - ORIC CFD

5.22
7.94%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.05
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025457%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.003235%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Oric Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 5.67
开仓* 5.54
1 年变化* 23.94%
日范围* 5.22 - 5.63
52 周范围 2.36-6.85
平均交易量(10 天) 254.10K
平均交易量(3 个月) 3.71M
市值 248.46M
市盈率 -100.00K
流通股 45.09M
收入 N/A
EPS -2.19
股息(收益率 %) N/A
贝塔 -100.00K
下一个财报发布日期 Aug 9, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平仓 Change Change (%) 開倉 High Low
Jun 7, 2023 5.67 0.39 7.39% 5.28 5.89 5.28
Jun 6, 2023 5.47 0.16 3.01% 5.31 5.61 5.23
Jun 5, 2023 5.28 0.05 0.96% 5.23 5.31 5.06
Jun 2, 2023 5.26 -0.01 -0.19% 5.27 5.40 5.26
Jun 1, 2023 5.25 0.27 5.42% 4.98 5.36 4.89
May 31, 2023 4.97 0.07 1.43% 4.90 5.01 4.86
May 30, 2023 5.01 -0.03 -0.60% 5.04 5.08 4.94
May 26, 2023 5.01 0.00 0.00% 5.01 5.11 4.99
May 25, 2023 5.13 0.04 0.79% 5.09 5.16 4.97
May 24, 2023 5.13 -0.01 -0.19% 5.14 5.20 4.99
May 23, 2023 5.16 -0.03 -0.58% 5.19 5.41 5.13
May 22, 2023 5.19 0.26 5.27% 4.93 5.20 4.93
May 19, 2023 4.94 0.02 0.41% 4.92 5.04 4.89
May 18, 2023 4.91 -0.02 -0.41% 4.93 5.01 4.85
May 17, 2023 4.96 0.02 0.40% 4.94 5.05 4.83
May 16, 2023 4.99 -0.10 -1.96% 5.09 5.17 4.95
May 15, 2023 5.10 0.00 0.00% 5.10 5.21 5.01
May 12, 2023 5.08 -0.12 -2.31% 5.20 5.20 5.05
May 11, 2023 5.15 0.07 1.38% 5.08 5.25 4.99
May 10, 2023 5.12 0.26 5.35% 4.86 5.27 4.85

ORIC Pharmaceuticals, Inc. Events

时间(协调世界时) (UTC) 国家/地区 事件
Wednesday, June 14, 2023

时间(协调世界时) (UTC)

15:00

国家/地区

US

事件

Oric Pharmaceuticals Inc Annual Shareholders Meeting
Oric Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Friday, June 16, 2023

时间(协调世界时) (UTC)

15:00

国家/地区

US

事件

Oric Pharmaceuticals Inc Annual Shareholders Meeting
Oric Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, August 9, 2023

时间(协调世界时) (UTC)

10:59

国家/地区

US

事件

Q2 2023 Oric Pharmaceuticals Inc Earnings Release
Q2 2023 Oric Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Monday, November 6, 2023

时间(协调世界时) (UTC)

21:05

国家/地区

US

事件

Q3 2023 Oric Pharmaceuticals Inc Earnings Release
Q3 2023 Oric Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 0 0 0 0 0
总营业费用 91.767 78.871 74.186 28.569 22.371
销售/一般/行政费用,总计 25.087 22.013 13.422 5.725 3.345
研究与开发 66.68 56.858 35.921 22.844 19.026
营业收入 -91.767 -78.871 -74.186 -28.569 -22.371
利息收入(费用),非经营净值 2.645 0.141 0.306 1.397 0.775
其他,净值 0 0.015 0.177 0.289 0.233
税前净收入 -89.122 -78.715 -73.703 -26.883 -21.363
税后净收入 -89.122 -78.715 -73.703 -26.883 -21.363
未计算非常项目前的净收益 -89.122 -78.715 -73.703 -26.883 -21.363
净收入 -89.122 -78.715 -73.703 -26.883 -21.363
普通股股东可获收益 (不含非经常性项目) -89.122 -78.715 -73.703 -26.883 -21.363
普通股股东可获收益 (含非經常性項目) -89.122 -78.715 -73.703 -26.883 -21.363
摊薄净收入 -89.122 -78.715 -73.703 -26.883 -21.363
摊薄后加权平均股 39.6553 37.9543 21.9425 27.5424 27.5424
扣除特别项目的每股摊薄盈利 -2.24742 -2.07394 -3.35892 -0.97606 -0.77564
Dividends per Share - Common Stock Primary Issue 0 0
每股正常摊薄盈利 -2.24742 -2.07394 -2.22673 -0.97606 -0.77564
异常费用(收入) 0 24.843
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
总收入 0 0 0 0 0
总营业费用 25.678 22.119 25.694 20.696 23.258
销售/一般/行政费用,总计 6.162 5.824 5.971 6.862 6.43
研究与开发 19.516 16.295 19.723 13.834 16.828
营业收入 -25.678 -22.119 -25.694 -20.696 -23.258
利息收入(费用),非经营净值 1.733 1.272 0.865 0.409 0.099
其他,净值 0
税前净收入 -23.945 -20.847 -24.829 -20.287 -23.159
税后净收入 -23.945 -20.847 -24.829 -20.287 -23.159
未计算非常项目前的净收益 -23.945 -20.847 -24.829 -20.287 -23.159
净收入 -23.945 -20.847 -24.829 -20.287 -23.159
普通股股东可获收益 (不含非经常性项目) -23.945 -20.847 -24.829 -20.287 -23.159
普通股股东可获收益 (含非經常性項目) -23.945 -20.847 -24.829 -20.287 -23.159
摊薄净收入 -23.945 -20.847 -24.829 -20.287 -23.159
摊薄后加权平均股 45.0902 40.1305 39.5757 39.4816 39.4317
扣除特别项目的每股摊薄盈利 -0.53105 -0.51948 -0.62738 -0.51383 -0.58732
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.53105 -0.51948 -0.62738 -0.51383 -0.58732
异常费用(收入)
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 210.457 240.522 296.697 89.999 43.724
现金和短期投资 206.272 236.979 293.6 89.159 42.636
现金等价物 66.84 226.006 78.446 89.159 42.636
Prepaid Expenses 4.185 3.543 3.097 0.84 1.088
Total Assets 247.178 298.642 298.997 94.093 46.734
Property/Plant/Equipment, Total - Net 3.253 2.413 1.981 2.241 2.514
Property/Plant/Equipment, Total - Gross 9.046 7.402 6.466 5.756 5.092
Accumulated Depreciation, Total -5.793 -4.989 -4.485 -3.515 -2.578
Other Long Term Assets, Total 11.517 12.321 0.319 1.853 0.496
Total Current Liabilities 15.388 15.151 9.002 5.354 2.596
Accounts Payable 1.32 1.886 0.757 0.152 0.446
Accrued Expenses 14.068 13.265 7.699 4.668 1.597
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.546 0.534 0.553
Total Liabilities 24.827 25.666 9.221 6.119 3.894
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 9.439 10.515 0.219 0.765 1.298
Total Equity 222.351 272.976 289.776 87.974 42.84
Preferred Stock - Non Redeemable, Net 178.058 107.266
Common Stock 0.005 0.004 0.004 0.001 0.001
Additional Paid-In Capital 557.867 518.183 456.196 2.605 1.38
Retained Earnings (Accumulated Deficit) -335.521 -245.211 -166.424 -92.69 -65.807
Total Liabilities & Shareholders’ Equity 247.178 298.642 298.997 94.093 46.734
Total Common Shares Outstanding 45.0895 39.4301 36.6724 27.5424 27.5424
短期投资 139.432 10.973 215.154
Long Term Investments 21.951 43.386
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
流动资产总额 193.164 210.457 198.685 233.526 239.085
现金和短期投资 189.629 206.272 193.659 227.064 234.622
现金等价物 58.99 66.84 29.076 49.08 112.644
短期投资 130.639 139.432 164.583 177.984 121.978
Prepaid Expenses 3.535 4.185 5.026 6.462 4.463
Total Assets 226.648 247.178 237.997 259.684 275.062
Property/Plant/Equipment, Total - Net 3.112 3.253 3.049 3.005 2.463
Property/Plant/Equipment, Total - Gross 9.158 9.046 8.684 8.456 7.692
Accumulated Depreciation, Total -6.046 -5.793 -5.635 -5.451 -5.229
Other Long Term Assets, Total 11.063 11.517 11.953 12.381 11.937
Total Current Liabilities 14.867 15.388 13.284 12.474 11.817
Accounts Payable 1.93 1.32 1.532 2.093 0.888
Accrued Expenses 12.937 14.068 11.752 10.381 10.929
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 23.836 24.827 23.178 22.814 21.983
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 8.969 9.439 9.894 10.34 10.166
Total Equity 202.812 222.351 214.819 236.87 253.079
Common Stock 0.005 0.005 0.004 0.004 0.004
Additional Paid-In Capital 561.481 557.867 529.945 526.651 522.144
Retained Earnings (Accumulated Deficit) -358.674 -335.521 -315.13 -289.785 -269.069
Total Liabilities & Shareholders’ Equity 226.648 247.178 237.997 259.684 275.062
Total Common Shares Outstanding 45.0912 45.0895 39.576 39.5755 39.4386
Long Term Investments 19.309 21.951 24.31 10.772 21.577
Other Current Liabilities, Total
Preferred Stock - Non Redeemable, Net 0 0 0
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -89.122 -78.715 -73.703 -26.883 -21.363
经营活动产生的现金 -75.143 -59.541 -45.268 -23.533 -20.683
经营活动产生的现金 0.966 0.897 0.97 1.028 0.903
非现金物品 13.458 14.204 25.42 1.102 0.484
营运资金的变化 -0.445 4.073 2.045 1.22 -0.707
投资活动产生的现金 -109.248 158.435 -215.959 -0.768 -0.508
资本支出 -2.078 -0.939 -0.667 -0.768 -0.525
其他投资现金流量项目,总计 -107.17 159.374 -215.292 0 0.017
融资活动产生的现金 25.225 49.134 250.514 70.824 38.008
融资现金流项目 -0.399 -1.852 -21.237 -0.099 0
股票的发行(报废),净额 25.624 50.986 271.751 70.923 38.008
现金净变化 -159.166 148.028 -10.713 46.523 16.817
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -23.945 -89.122 -68.275 -43.446 -23.159
Cash From Operating Activities -20.628 -75.143 -59.814 -40.494 -22.718
Cash From Operating Activities 0.253 0.966 0.719 0.498 0.251
Non-Cash Items 2.753 13.458 10.908 7.985 3.987
Changes in Working Capital 0.311 -0.445 -3.166 -5.531 -3.797
Cash From Investing Activities 12.778 -109.248 -137.548 -136.863 -90.66
Capital Expenditures -0.31 -2.078 -1.791 -1.39 -0.723
Other Investing Cash Flow Items, Total 13.088 -107.17 -135.757 -135.473 -89.937
Cash From Financing Activities 0 25.225 0.432 0.431 0.016
Issuance (Retirement) of Stock, Net 0 25.624 0.432 0.431 0.016
Net Change in Cash -7.85 -159.166 -196.93 -176.926 -113.362
Financing Cash Flow Items -0.399 0
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Pfizer Inc Corporation 11.9227 5376344 5376344 2022-12-23 MED
Fidelity Management & Research Company LLC Investment Advisor 8.8843 4006224 -9509 2023-03-31 LOW
The Column Group LP Venture Capital 7.9129 3568181 0 2023-03-31 LOW
EcoR1 Capital, LLC Hedge Fund 7.58 3418068 0 2023-03-31 LOW
Millennium Management LLC Hedge Fund 5.0288 2267642 -166208 2023-03-31 HIGH
Alkeon Capital Management LLC Investment Advisor/Hedge Fund 4.4668 2014241 0 2023-03-31 LOW
Suvretta Capital Management, LLC Hedge Fund 4.2194 1902643 0 2023-03-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.6437 1643074 96789 2023-03-31 LOW
Prosight Capital Hedge Fund 3.4262 1545000 365000 2023-03-31 HIGH
SilverArc Capital Management, LLC Hedge Fund 3.1844 1435945 199649 2023-03-31 HIGH
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 3.0481 1374468 -233100 2023-03-31 LOW
Boxer Capital, L.L.C. Hedge Fund 2.3374 1054000 0 2023-03-31 LOW
Invus Financial Advisors, LLC Hedge Fund 2.2344 1007575 0 2023-03-31 LOW
Chacko (Jacob M) Individual Investor 1.811 816652 3471 2023-03-31 LOW
Euclidean Capital, L.L.C. Investment Advisor 1.6578 747550 0 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.5144 682888 -107508 2023-03-31 LOW
Memorial Sloan-Kettering Cancer Center Investment Advisor 1.3356 602272 0 2023-03-31 LOW
D. E. Shaw & Co., L.P. Hedge Fund 1.2825 578303 -24484 2023-03-31 LOW
Monaco asset management S.A.M. Investment Advisor 1.2236 551749 -5681 2023-03-31 HIGH
Oppenheimer Asset Management Inc. Investment Advisor 0.8538 385011 0 2023-03-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

535K+

交易者

87K+

每月活跃客户

$113M+

每月投资额

$64M+

每月提取金额

交易计算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

交易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投资
交易规模(杠杆 x 投资):
開倉

平仓

做空 做多

ORIC Pharmaceuticals, Inc. Company profile

关于 ORIC Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc.是一家临床阶段的生物制药公司,致力于通过克服癌症的抗药性来改善患者的生活。 公司专注于开发多样化的疗法,旨在利用其在三个特定领域的经验来对抗癌症的抗药性机制:激素依赖性癌症、精准肿瘤学和关键肿瘤依赖性。 其候选产品包括ORIC-101、ORIC-533、ORIC-944和ORIC-114。 公司的ORIC-101是一种强效和选择性的糖皮质激素受体(GR)的小分子拮抗剂,该受体与各种实体瘤对多类癌症治疗药物的抗性有关。 公司的第二个候选产品ORIC-533是一种可口服的CD73小分子抑制剂,CD73是化疗和免疫疗法治疗方案中腺苷途径的一个关键节点。 其ORIC-944正在开发用于治疗前列腺癌和乳腺癌。

Industry: Bio Therapeutic Drugs

240 E. Grand Ave.
2Nd Floor
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,965.34 Price
+1.270% 1D Chg, %
多头隔夜费 -0.0185%
空头隔夜费 0.0103%
隔夜费时间 21:00 (UTC)
价差 0.30

US100

14,475.70 Price
+1.310% 1D Chg, %
多头隔夜费 -0.0255%
空头隔夜费 0.0032%
隔夜费时间 21:00 (UTC)
价差 1.8

Oil - Crude

70.90 Price
-2.210% 1D Chg, %
多头隔夜费 -0.0153%
空头隔夜费 -0.0066%
隔夜费时间 21:00 (UTC)
价差 0.03

XRP/USD

0.53 Price
+0.120% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00408

还在找一位您可以信任的经纪商吗?

加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易